This occurs either through reactivation of telomerase (∼85% of cancers), or via the poorly characterized Alternative Lengthening of Telomeres (ALT) mechanism that requires the homologous recombination (HR) machinery (∼15% of cancers) (11,12). This evidence concerns the gene GPT and cancer.